Curing HCV Yields Long-Term Improvement in Quality of Life

Hepatitis C patients who attained sustained virologic response (SVR) with a direct-acting antiviral (DAA) drug maintained health improvements that enhanced their long-term quality of life, a new study shows. Reaching SVR, considered a cure for chronic hepatitis C (HCV), has been associated with clinical benefits and short-term improvement in health-related quality of life (HRQL) scores. However, the sustainability of these improvements is unknown, the res